Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Mitochondrial 4-HNE derived from MAO-A promotes mitoCa2+ overload in chronic postischemic cardiac remodeling.

Santin Y, Fazal L, Sainte-Marie Y, Sicard P, Maggiorani D, Tortosa F, Yücel YY, Teyssedre L, Rouquette J, Marcellin M, Vindis C, Shih JC, Lairez O, Burlet-Schiltz O, Parini A, Lezoualc'h F, Mialet-Perez J.

Cell Death Differ. 2019 Dec 9. doi: 10.1038/s41418-019-0470-y. [Epub ahead of print]

PMID:
31819159
2.

Aging induces cardiac mesenchymal stromal cell senescence and promotes endothelial cell fate of the CD90 + subset.

Martini H, Iacovoni JS, Maggiorani D, Dutaur M, Marsal DJ, Roncalli J, Itier R, Dambrin C, Pizzinat N, Mialet-Perez J, Cussac D, Parini A, Lefevre L, Douin-Echinard V.

Aging Cell. 2019 Oct;18(5):e13015. doi: 10.1111/acel.13015. Epub 2019 Jul 29.

3.

Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress.

Laudette M, Coluccia A, Sainte-Marie Y, Solari A, Fazal L, Sicard P, Silvestri R, Mialet-Perez J, Pons S, Ghaleh B, Blondeau JP, Lezoualc'h F.

Cardiovasc Res. 2019 Oct 1;115(12):1766-1777. doi: 10.1093/cvr/cvz076.

PMID:
30873562
4.

Length-independent telomere damage drives post-mitotic cardiomyocyte senescence.

Anderson R, Lagnado A, Maggiorani D, Walaszczyk A, Dookun E, Chapman J, Birch J, Salmonowicz H, Ogrodnik M, Jurk D, Proctor C, Correia-Melo C, Victorelli S, Fielder E, Berlinguer-Palmini R, Owens A, Greaves LC, Kolsky KL, Parini A, Douin-Echinard V, LeBrasseur NK, Arthur HM, Tual-Chalot S, Schafer MJ, Roos CM, Miller JD, Robertson N, Mann J, Adams PD, Tchkonia T, Kirkland JL, Mialet-Perez J, Richardson GD, Passos JF.

EMBO J. 2019 Mar 1;38(5). pii: e100492. doi: 10.15252/embj.2018100492. Epub 2019 Feb 8.

5.

Monoamine oxidase-A, serotonin and norepinephrine: synergistic players in cardiac physiology and pathology.

Mialet-Perez J, Santin Y, Parini A.

J Neural Transm (Vienna). 2018 Nov;125(11):1627-1634. doi: 10.1007/s00702-018-1908-y. Epub 2018 Jul 24. Review.

PMID:
30043181
6.

Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy.

Manzella N, Santin Y, Maggiorani D, Martini H, Douin-Echinard V, Passos JF, Lezoualc'h F, Binda C, Parini A, Mialet-Perez J.

Aging Cell. 2018 Oct;17(5):e12811. doi: 10.1111/acel.12811. Epub 2018 Jul 12.

7.

Oleuropein Aglycone Protects against MAO-A-Induced Autophagy Impairment and Cardiomyocyte Death through Activation of TFEB.

Miceli C, Santin Y, Manzella N, Coppini R, Berti A, Stefani M, Parini A, Mialet-Perez J, Nediani C.

Oxid Med Cell Longev. 2018 Mar 26;2018:8067592. doi: 10.1155/2018/8067592. eCollection 2018.

8.

Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis.

Reis J, Manzella N, Cagide F, Mialet-Perez J, Uriarte E, Parini A, Borges F, Binda C.

J Med Chem. 2018 May 10;61(9):4203-4212. doi: 10.1021/acs.jmedchem.8b00357. Epub 2018 Apr 20.

PMID:
29648817
9.

Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine.

Carpéné C, Mercader J, Le Gonidec S, Schaak S, Mialet-Perez J, Zakaroff-Girard A, Galitzky J.

Br J Pharmacol. 2018 Jun;175(12):2428-2440. doi: 10.1111/bph.14211. Epub 2018 May 6.

10.

Autophagy in health and disease: focus on the cardiovascular system.

Mialet-Perez J, Vindis C.

Essays Biochem. 2017 Dec 12;61(6):721-732. doi: 10.1042/EBC20170022. Print 2017 Dec 12. Review.

PMID:
29233881
11.

Major depression and heart failure: Interest of monoamine oxidase inhibitors.

Corbineau S, Breton M, Mialet-Perez J, Costemale-Lacoste JF.

Int J Cardiol. 2017 Nov 15;247:1-6. doi: 10.1016/j.ijcard.2017.07.005. Epub 2017 Jul 8. Review.

PMID:
28705604
12.

Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing.

Maggiorani D, Manzella N, Edmondson DE, Mattevi A, Parini A, Binda C, Mialet-Perez J.

Oxid Med Cell Longev. 2017;2017:3017947. doi: 10.1155/2017/3017947. Epub 2017 May 4. Review.

13.

Multifunctional Mitochondrial Epac1 Controls Myocardial Cell Death.

Fazal L, Laudette M, Paula-Gomes S, Pons S, Conte C, Tortosa F, Sicard P, Sainte-Marie Y, Bisserier M, Lairez O, Lucas A, Roy J, Ghaleh B, Fauconnier J, Mialet-Perez J, Lezoualc'h F.

Circ Res. 2017 Feb 17;120(4):645-657. doi: 10.1161/CIRCRESAHA.116.309859. Epub 2017 Jan 17.

PMID:
28096195
14.

Oxidative Stress by Monoamine Oxidase-A Impairs Transcription Factor EB Activation and Autophagosome Clearance, Leading to Cardiomyocyte Necrosis and Heart Failure.

Santin Y, Sicard P, Vigneron F, Guilbeau-Frugier C, Dutaur M, Lairez O, Couderc B, Manni D, Korolchuk VI, Lezoualc'h F, Parini A, Mialet-Perez J.

Antioxid Redox Signal. 2016 Jul 1;25(1):10-27. doi: 10.1089/ars.2015.6522. Epub 2016 Apr 22.

PMID:
26959532
15.

High intake of dietary tyramine does not deteriorate glucose handling and does not cause adverse cardiovascular effects in mice.

Carpéné C, Schaak S, Guilbeau-Frugier C, Mercader J, Mialet-Perez J.

J Physiol Biochem. 2016 Sep;72(3):539-53. doi: 10.1007/s13105-015-0456-2. Epub 2015 Dec 3.

PMID:
26634369
16.

[Ageing: a matter of heart?].

Mialet-Perez J, Douin-Echinard V, Cussac D, Bril A, Parini A.

Med Sci (Paris). 2015 Nov;31(11):1006-13. doi: 10.1051/medsci/20153111015. Epub 2015 Nov 17. Review. French.

17.

Gadd45γ regulates cardiomyocyte death and post-myocardial infarction left ventricular remodelling.

Lucas A, Mialet-Perez J, Daviaud D, Parini A, Marber MS, Sicard P.

Cardiovasc Res. 2015 Nov 1;108(2):254-67. doi: 10.1093/cvr/cvv219. Epub 2015 Sep 14.

PMID:
26370247
18.

Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis.

Rouzaud-Laborde C, Delmas C, Pizzinat N, Tortosa F, Garcia C, Mialet-Perez J, Payrastre B, Sié P, Spreux-Varoquaux O, Sallerin B, Carrié D, Galinier M, Parini A, Lairez O.

Am J Hematol. 2015 Jan;90(1):15-9. doi: 10.1002/ajh.23855.

19.

Monoamine oxidases as sources of oxidants in the heart.

Kaludercic N, Mialet-Perez J, Paolocci N, Parini A, Di Lisa F.

J Mol Cell Cardiol. 2014 Aug;73:34-42. doi: 10.1016/j.yjmcc.2013.12.032. Epub 2014 Jan 9. Review.

20.

First evidence of increased plasma serotonin levels in Tako-Tsubo cardiomyopathy.

Rouzaud Laborde C, Delmas C, Mialet-Perez J, Pizzinat N, Biendel-Picquet C, Boudou N, Dumonteil N, Spreux-Varoquaux O, Carrié D, Galinier M, Parini A, Lairez O.

Biomed Res Int. 2013;2013:847069. doi: 10.1155/2013/847069. Epub 2013 Sep 23.

21.

Anesthetic regimen for cardiac function evaluation by echocardiography in mice: comparison between ketamine, etomidate and isoflurane versus conscious state.

Lairez O, Lonjaret L, Ruiz S, Marchal P, Franchitto N, Calise D, Fourcade O, Mialet-Perez J, Parini A, Minville V.

Lab Anim. 2013 Oct;47(4):284-90. doi: 10.1177/0023677213496236. Epub 2013 Jul 17.

PMID:
23864007
22.

Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice.

Lairez O, Cognet T, Schaak S, Calise D, Guilbeau-Frugier C, Parini A, Mialet-Perez J.

J Neural Transm (Vienna). 2013 Jun;120(6):927-35. doi: 10.1007/s00702-013-1011-3. Epub 2013 Mar 30.

PMID:
23543114
23.

p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice.

Villeneuve C, Guilbeau-Frugier C, Sicard P, Lairez O, Ordener C, Duparc T, De Paulis D, Couderc B, Spreux-Varoquaux O, Tortosa F, Garnier A, Knauf C, Valet P, Borchi E, Nediani C, Gharib A, Ovize M, Delisle MB, Parini A, Mialet-Perez J.

Antioxid Redox Signal. 2013 Jan 1;18(1):5-18. doi: 10.1089/ars.2011.4373. Epub 2012 Aug 10.

24.

Serotonin 5-HT2A receptor-mediated hypertrophy is negatively regulated by caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes.

Mialet-Perez J, D'Angelo R, Villeneuve C, Ordener C, Nègre-Salvayre A, Parini A, Vindis C.

J Mol Cell Cardiol. 2012 Feb;52(2):502-10. doi: 10.1016/j.yjmcc.2011.07.019. Epub 2011 Jul 28.

PMID:
21820441
25.

Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors.

Vindis C, D'Angelo R, Mucher E, Nègre-Salvayre A, Parini A, Mialet-Perez J.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):979-83. doi: 10.1016/j.bbrc.2009.12.001. Epub 2009 Dec 11.

PMID:
20005206
26.

Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells.

Villeneuve C, Caudrillier A, Ordener C, Pizzinat N, Parini A, Mialet-Perez J.

Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H821-8. doi: 10.1152/ajpheart.00345.2009. Epub 2009 Jun 19.

27.

Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors.

Yabanoglu S, Akkiki M, Seguelas MH, Mialet-Perez J, Parini A, Pizzinat N.

J Mol Cell Cardiol. 2009 Apr;46(4):518-25. doi: 10.1016/j.yjmcc.2008.12.019. Epub 2009 Jan 9.

PMID:
19167402
28.

Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.

Lairez O, Calise D, Bianchi P, Ordener C, Spreux-Varoquaux O, Guilbeau-Frugier C, Escourrou G, Seif I, Roncalli J, Pizzinat N, Galinier M, Parini A, Mialet-Perez J.

J Mol Cell Cardiol. 2009 Apr;46(4):587-95. doi: 10.1016/j.yjmcc.2008.12.017. Epub 2009 Jan 7.

PMID:
19162038
29.

Genetic variation within the beta1-adrenergic receptor gene results in haplotype-specific expression phenotypes.

Small KM, Mialet-Perez J, Liggett SB.

J Cardiovasc Pharmacol. 2008 Jan;51(1):106-10. doi: 10.1097/FJC.0b013e31815a958f.

PMID:
18209576
30.

New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart.

Mialet-Perez J, Bianchi P, Kunduzova O, Parini A.

J Neural Transm (Vienna). 2007;114(6):823-7. Epub 2007 Apr 30. Review.

PMID:
17473906
31.

Genetic variation of human adrenergic receptors: from molecular and functional properties to clinical and pharmacogenetic implications.

Schaak S, Mialet-Perez J, Flordellis C, Paris H.

Curr Top Med Chem. 2007;7(2):217-31. Review.

PMID:
17266608
32.

Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension.

Mialet-Perez J, Liggett SB.

Arch Mal Coeur Vaiss. 2006 Jun;99(6):616-20. Review.

PMID:
16878723
33.

A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.

Liggett SB, Mialet-Perez J, Thaneemit-Chen S, Weber SA, Greene SM, Hodne D, Nelson B, Morrison J, Domanski MJ, Wagoner LE, Abraham WT, Anderson JL, Carlquist JF, Krause-Steinrauf HJ, Lazzeroni LC, Port JD, Lavori PW, Bristow MR.

Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11288-93. Epub 2006 Jul 14.

34.

Myocardial beta1-adrenergic receptor polymorphisms affect functional recovery after ischemic injury.

Akhter SA, D'Souza KM, Petrashevskaya NN, Mialet-Perez J, Liggett SB.

Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1427-32.

35.

Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes.

Castro L, Mialet-Perez J, Guillemeau A, Stillitano F, Zolk O, Eschenhagen T, Lezoualc'h F, Bochet P, Fischmeister R.

J Mol Cell Cardiol. 2005 Aug;39(2):335-44.

PMID:
15950987
36.

Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects.

Small KM, Mialet-Perez J, Seman CA, Theiss CT, Brown KM, Liggett SB.

Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):13020-5. Epub 2004 Aug 19.

37.

A primate-dominant third glycosylation site of the beta2-adrenergic receptor routes receptors to degradation during agonist regulation.

Mialet-Perez J, Green SA, Miller WE, Liggett SB.

J Biol Chem. 2004 Sep 10;279(37):38603-7. Epub 2004 Jul 9.

38.

Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.

Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A, Dorn GW, Liggett SB.

Nat Med. 2003 Oct;9(10):1300-5. Epub 2003 Sep 14.

PMID:
14502278

Supplemental Content

Loading ...
Support Center